CN112500364A - Synthesis process of 3, 4-dichloroisothiazole methyl ketone - Google Patents

Synthesis process of 3, 4-dichloroisothiazole methyl ketone Download PDF

Info

Publication number
CN112500364A
CN112500364A CN202110006448.4A CN202110006448A CN112500364A CN 112500364 A CN112500364 A CN 112500364A CN 202110006448 A CN202110006448 A CN 202110006448A CN 112500364 A CN112500364 A CN 112500364A
Authority
CN
China
Prior art keywords
dichloroisothiazole
methyl ketone
reaction
compound
proportion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110006448.4A
Other languages
Chinese (zh)
Inventor
范志金
吕游
李坤
王炜博
郝泽生
齐欣
刘笑宇
高卫
张越
陈蕾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nankai University
Original Assignee
Nankai University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nankai University filed Critical Nankai University
Priority to CN202110006448.4A priority Critical patent/CN112500364A/en
Publication of CN112500364A publication Critical patent/CN112500364A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides a synthesis process for preparing 3, 4-dichloroisothiazole methyl ketone, and also discloses a purification method of the compound; the chemical structure of the 3, 4-dichloroisothiazole methyl ketone is shown in formula I: i:

Description

Synthesis process of 3, 4-dichloroisothiazole methyl ketone
Technical Field
The invention relates to an isothiazole methyl ketone derivative, which specifically comprises the following components in part by weight: the invention relates to 3, 4-dichloroisothiazole methyl ketone, and relates to a preparation method and a process route of the compound.
Background
The heterocyclic compound is an important source for the structure development of pesticides, and is a common high-efficiency, low-toxicity and broad-spectrum bioactive lead compound. Most of active molecules reported in the literature have heterocyclic structures. In the related pesticide patents, N-containing heterocycles (pyridine, pyrazole, pyrimidine and the like), sulfur-containing heterocycles, thiazole, fused heterocycles and the like account for more than half of the total number, but N-and S-containing compounds (including thiazole, isothiazole, thiadiazole and the like) often have wide biological activity. 3, 4-dichloroisothiazolemethyl ketone is a key intermediate for many pesticide molecules.
The strobilurin fungicide has broad-spectrum bactericidal activity and has good activity on almost all fungal diseases (ascomycetes, basidiomycetes, oomycetes and fungi imperfecti). In order to find and discover a pesticide lead compound which is more efficient, broad-spectrum, low-toxicity and low-ecological risk and has no cross resistance with the existing bactericide, an isothiazole pharmacophore 3, 4-dichloroisothiazole ring containing N and S is introduced into a methoxyacrylate parent structure, so that an isothiazole oxime ether methoxyacrylate bactericidal candidate compound can be obtained. Biological activity screening finds a plurality of high-activity compounds; 3, 4-dichloroisothiazole methyl ketone is a key intermediate for synthesizing isothiazole oxime ether methoxy acrylate bactericidal compounds. The invention carries out systematic research on the synthesis process of the intermediate, and lays a foundation for the production and industrialization of the series of high-activity compounds (Van Shijin and the like, a class of isothiazole oxime ether methoxy acrylate derivatives, a preparation method and application thereof, the invention patent of the people's republic of China, the application date of which is 3 and 25 in 2016, and the application number of which is 201610185795.7).
The literature reports that the synthetic route of 3, 4-dichloroisothiazole methyl ketone has two routes: 3, 4-dichloroisothiazole-5-formic acid and methoxy methylamine hydrochloride are firstly reacted with each other to obtain a methoxy substituted 3, 4-dichloroisothiazole formamide intermediate under the action of a condensing agent (EDCI), and the intermediate and a methyl Grignard reagent are subjected to substitution reaction in a tetrahydrofuran solvent at minus 30 ℃ to obtain a target product (RSC Advances 2017, 7(6), 3145-one 3151); the method needs methyl Grignard reagent, has high cost, strict control of anhydrous operation, high production difficulty, strict requirement on equipment and poor reaction repeatability. The other route is as follows: 3, 4-dichloroisothiazole-5-formyl chloride and Meldrum's acid are subjected to condensation reaction under the action of alkali to obtain an intermediate, and the intermediate is heated and decarboxylated under the condition of strong acid to obtain a target product (WO 03031240A 1); the yield of the intermediate prepared in the first step of the route is low, only 40 percent, so that the overall yield of the route is low, and the price of the Meldrum's acid is high, so that if the existing synthetic route is used for industrial production, various problems exist, the reaction route is further optimized, and a new route suitable for industrial large-scale production is developed.
The invention improves the synthesis process of the 3, 4-dichloroisothiazole methyl ketone and provides two new synthesis routes; lays a foundation for the deep research and the industrial development of the compound.
Disclosure of Invention
The technical problem to be solved by the invention is as follows: provides a new synthesis process of the 3, 4-dichloroisothiazole methyl ketone, and provides a technical basis and support for industrial production.
The technical scheme adopted by the invention for solving the technical problem is as follows: optimizes the synthesis process route of the intermediate 3, 4-dichloroisothiazole methyl ketone with bactericidal activity.
The chemical structural formula of the 3, 4-dichloroisothiazole methyl ketone is as follows:
Figure BSA0000229611300000021
two process routes for synthesizing the 3, 4-dichloroisothiazole methyl ketone I of the invention are specifically described as follows:
the specific operation steps for preparing the 3, 4-dichloroisothiazole methyl ketone I by utilizing the beta-keto ester are as follows:
Figure BSA0000229611300000022
R1selected from: methyl, ethyl, alkyl; the catalyst is selected from: trichloroAluminum oxide, silver tetrafluoroborate, boron trifluoride, sulfur trioxide, and ferric bromide or other lewis acids.
The specific operation steps for preparing the 3, 4-dichloroisothiazole methyl ketone I by utilizing the beta-keto ester are as follows:
compound II (5.0 mmol), catalyst (0.25 mmol), water (0.18g, 10.0 mmol) and 5.0 ml of acetic acid were added to a 100 ml round bottom flask and reacted under reflux for a certain period of time; after the reaction is finished, cooling, standing, filtering off insoluble substances, adding a proper amount of water, extracting with ethyl acetate, combining organic phases, washing with saturated saline solution, and drying with anhydrous sodium sulfate; evaporating the solvent under reduced pressure to obtain a light yellow solid I; the amount of the compound can be enlarged or reduced according to the corresponding proportion, the material ratio A to the catalyst is selected from any proportion between 1000: 1 and 10: 1, the reaction time is selected from any time between 5 hours and 20 hours, and the material ratio A to the water is selected from any proportion between 1: 1 and 1: 5.
The specific operation steps for preparing the 3, 4-dichloroisothiazole methyl ketone I by using the 1, 3-diester are as follows:
Figure BSA0000229611300000023
R2selected from: methyl, ethyl, alkyl;
Figure BSA0000229611300000024
selected from: hydrochloric acid, sulfuric acid, p-toluenesulfonic acid, or other strong acids.
The specific operation steps for preparing the 3, 4-dichloroisothiazole methyl ketone I by using the 1, 3-diester are as follows:
dissolving the compound III by using glacial acetic acid, adding a little strong acid for catalysis, and heating for reaction; after the reaction is finished, cooling, standing, filtering off insoluble substances, adding a proper amount of water, extracting with ethyl acetate, combining organic phases, washing with saturated saline solution, and drying with anhydrous sodium sulfate; evaporating the solvent under reduced pressure to obtain a light yellow solid I; the dosage of the compound can be enlarged or reduced according to the corresponding proportion, the material ratio III to the strong acid is selected from any proportion between 1000: 1 and 10: 1, the reaction time is selected from any time between 1 hour and 24 hours, and the reaction temperature is selected from any temperature between 40 ℃ and 120 ℃.
Example 1. synthetic route to 3, 4-dichloroisothiazole methyl ketone I using beta-keto ester:
Figure BSA0000229611300000031
adding ethyl 3- (3, 4-dichloroisothiazol-5-yl) -3-oxopropanoate A (1.33 g, 5.0 mmol), silver tetrafluoroborate B (0.05 g, 0.25 mmol), water (0.18g, 10.0 mmol) and 5.0 ml of acetic acid into a 100 ml round-bottomed flask, heating and refluxing for a certain time, detecting the completion of the reaction, cooling and standing to filter out insoluble substances, adding an appropriate amount of water, extracting with ethyl acetate, washing the combined organic phases with saturated brine, and drying over anhydrous sodium sulfate; evaporating the solvent under reduced pressure to obtain a light yellow solid I;1H NMR(400MHz,CDCl3) δ 2.65(s, 3H). The dosage of the compound can be enlarged or reduced according to the corresponding proportion, the range of the material ratio A to the silver tetrafluoroborate is selected from any proportion between 1000: 1 and 10: 1, the reaction time is selected from any time between 5 hours and 20 hours, the adding amount range of the material ratio A to the water is selected from any proportion between 1: 1 and 1: 5, and the typical experiment result of condition optimization is shown in table 1. Table 1 shows that the optimized route selected by the present invention is the condition of data display in the first column, and the yield in the whole table is higher than about 40% of the reference in the introduction by at least 10%, therefore, the improvement of the process route is a significant technical progress.
Example 2. synthetic process route for preparing 3, 4-dichloroisothiazole methyl ketone I using 1, 3-diester as raw material:
Figure BSA0000229611300000032
compound E (1.70 g)5.0 mmol) was dissolved in 5.0 ml of glacial acetic acid, and concentrated sulfuric acid (49 mg, 0.5 mmol) was added thereto and heated under reflux for 6.0 hours; cooling to room temperature, adding appropriate amount of water, extracting with ethyl acetate, mixing organic phases, washing with saturated saline solution, and drying with anhydrous sodium sulfate; evaporating the solvent under reduced pressure to obtain a light yellow solid I;1H NMR(400MHz,CDCl3) δ 2.65(s, 3H); the dosage of the compound can be enlarged or reduced according to the corresponding proportion, the range of the material ratio E to the sulfuric acid is selected from any proportion between 1000: 1 and 10: 1, the reaction time is selected from any time between 5 hours and 24 hours, and the typical experimental result of condition optimization is shown in a table 2. As can be seen from Table 2, the invention screens out two optimized conditions of the route, the conditions shown in the data of the 4 th column and the 13 th column, the condition in the 13 th column greatly reduces the dosage of G, the route is the optimal route of the invention, the yield is higher than about 40% of the reference in the introduction by at least 10%, and the improvement of the process route has obvious technical progress.
TABLE 1 optimization of Process conditions for the preparation of 3, 4-dichloroisothiazole methyl ketone I using beta-keto esters
Serial number A/millimole B/millimole C/ml D/millimole Time per hour Temperature/degree centigrade Yield/%)
1 5 0.5 5 10 12 117 82
2 5 0.25 5 10 12 117 80
3 5 0.05 5 10 12 117 77
4 5 0.025 5 10 12 117 65
5 5 0.005 5 10 12 117 52
6 5 0.05 5 10 24 117 79
7 5 0.025 5 10 24 117 73
8 5 0.005 5 10 24 117 66
9 5 0.05 5 10 12 100 62
10 5 0.05 5 10 12 80 52
11 5 0.05 2.5 10 12 117 78
12 5 0.05 1.0 10 12 117 53
13 5 0.05 2.5 7.5 12 117 75
14 5 0.05 2.5 7.5 15 117 78
15 5 0.05 2.5 7.5 18 117 79
16 5 0.05 2.5 7.5 24 117 78
TABLE 2 optimization of Process conditions for the preparation of 3, 4-dichloroisothiazole methyl ketone I using 1, 3-diester as raw material
Serial number E/millimole F/millimole G/ml Time per hour Temperature/degree centigrade Yield/%)
1 5 0.5 5 12 117 68
2 5 0.5 5 10 117 66
3 5 0.5 5 8 117 67
4 5 0.5 5 6 117 68
5 5 0.5 5 4 117 55
6 5 0.05 5 6 117 65
7 5 0.025 5 6 117 60
8 5 0.01 5 6 117 58
9 5 0.005 5 6 117 45
10 5 0.05 5 6 100 52
11 5 0.05 5 6 80 43
12 5 0.05 2.5 6 117 64
13 5 0.05 1.0 6 117 62

Claims (2)

1. The synthesis process route for preparing the 3, 4-dichloroisothiazole methyl ketone I by utilizing the beta-keto ester is characterized by comprising the following reaction route:
Figure FSA0000229611290000011
R1selected from: methyl, ethyl, alkyl; the catalyst is selected from: aluminum trichloride, silver tetrafluoroborate, boron trifluoride, sulfur trioxide, ferric bromide and other lewis acids;
the specific operation steps for preparing the 3, 4-dichloroisothiazole methyl ketone I by utilizing the beta-keto ester are as follows:
compound II (5.0 mmol), catalyst (0.25 mmol), water (0.18g, 10.0 mmol) and 5.0 ml of acetic acid were added to a 100 ml round bottom flask and reacted under reflux for a certain period of time; after the reaction is finished, cooling, standing, filtering off insoluble substances, adding a proper amount of water, extracting with ethyl acetate, combining organic phases, washing with saturated saline solution, and drying with anhydrous sodium sulfate; evaporating the solvent under reduced pressure to obtain a light yellow solid I; the amount of the compound can be enlarged or reduced according to the corresponding proportion, the material ratio A to the catalyst is selected from any proportion between 1000: 1 and 10: 1, the reaction time is selected from any time between 5 hours and 20 hours, and the material ratio A to the water is selected from any proportion between 1: 1 and 1: 5.
2. The synthesis process route for preparing 3, 4-dichloroisothiazole methyl ketone I by using 1, 3-diester is characterized by comprising the following reaction route:
Figure FSA0000229611290000012
R2selected from: methyl, ethyl, alkyl;
Figure FSA0000229611290000013
selected from: hydrochloric acid, sulfuric acid, p-toluenesulfonic acid and other strong acids;
the specific operation steps for preparing the 3, 4-dichloroisothiazole methyl ketone I by using the 1, 3-diester are as follows:
dissolving the compound III by using glacial acetic acid, adding a little strong acid for catalysis, and heating for reaction; after the reaction is finished, cooling, standing, filtering off insoluble substances, adding a proper amount of water, extracting with ethyl acetate, combining organic phases, washing with saturated saline solution, and drying with anhydrous sodium sulfate; evaporating the solvent under reduced pressure to obtain a light yellow solid I; the dosage of the compound can be enlarged or reduced according to the corresponding proportion, the material ratio III to the strong acid is selected from any proportion between 1000: 1 and 10: 1, the reaction time is selected from any time between 1 hour and 24 hours, and the reaction temperature is selected from any temperature between 40 ℃ and 120 ℃.
CN202110006448.4A 2021-01-05 2021-01-05 Synthesis process of 3, 4-dichloroisothiazole methyl ketone Pending CN112500364A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110006448.4A CN112500364A (en) 2021-01-05 2021-01-05 Synthesis process of 3, 4-dichloroisothiazole methyl ketone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110006448.4A CN112500364A (en) 2021-01-05 2021-01-05 Synthesis process of 3, 4-dichloroisothiazole methyl ketone

Publications (1)

Publication Number Publication Date
CN112500364A true CN112500364A (en) 2021-03-16

Family

ID=74952315

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110006448.4A Pending CN112500364A (en) 2021-01-05 2021-01-05 Synthesis process of 3, 4-dichloroisothiazole methyl ketone

Country Status (1)

Country Link
CN (1) CN112500364A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102942565A (en) * 2012-11-06 2013-02-27 江西天人生态股份有限公司 3,4-dichloro isothiazole derivatives, their preparation method and application

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102942565A (en) * 2012-11-06 2013-02-27 江西天人生态股份有限公司 3,4-dichloro isothiazole derivatives, their preparation method and application

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEN, LAI ET AL: "Synthesis and fungicidal activity of 3,4-dichloroisothiazole based strobilurins as potent fungicide candidates", 《RSC ADVANCES》 *

Similar Documents

Publication Publication Date Title
CN109942364B (en) Olefin synthesis method using water as hydrogen source
CN102127024A (en) Method for synthesizing 4-aryl-1H-1,2,3-triazole by using 1,1-dibromo-1-olefin
CN112500364A (en) Synthesis process of 3, 4-dichloroisothiazole methyl ketone
CN109336753B (en) Synthetic method of alpha-benzyl substituted 1, 3-diketone compound
CN109369608B (en) Method for preparing benzo-1, 3-oxathiolane hexadiene-4-imine
CN109665990B (en) Boscalid synthesis process
CN108191919B (en) - 2 (1H) -one of 4- (substituted-phenyl) -6- ferrocenyl -3,4- dihydro-pyrimidin and preparation method thereof
CN105924397B (en) A kind of formic acid esters pyrazole compound of 1,5 diaryl 3, Preparation method and use
CN108675999A (en) A kind of acetic acid copper catalysis preparation 8-(9- sulfoxide group -10- dihydro phenanthrenes)The method of quinoline
CN108440312B (en) Preparation method of 2- (3,4) -dichlorophenyl-4-fluoroaniline
DE10131810A1 (en) Process for the production of optically active cyanohydrins and their corresponding acids
CN100434427C (en) Benzopyran kind compound and its preparation method
CN109096239B (en) Preparation route of 9-anthrone lactone framework compound and application of analogue thereof in antitumor aspect
CN108929276B (en) Method for preparing pyrimidine compounds from methyl ketone compounds and nitrile compounds
CN106431977B (en) A kind of unsaturated oximido ethers compound and application thereof
CN114436803B (en) Preparation method of 3- (4-chlorophenyl) -1, 5-diphenylpentane-1, 5-dione compound
CN101412667B (en) Preparation of 2-pimelie kelone compound
CN105777773B (en) Thiophene [2,3 b] quinoline and its synthetic method and application
CN114957113B (en) 2-chloroquinoline-3-formaldehyde oxime-O- (N-p-fluorophenyl) carbamate and preparation method and application thereof
CN106810430A (en) A kind of preparation method of the naphthoquinone derivatives of 2 trifluoromethyl 1,4
CN111892582B (en) Preparation method of benzofuran coumarin compound
CN109897052B (en) N-pyrimidinyl-1, 3-oxaza bridge ring compound and preparation method and application thereof
CN112441997B (en) Method for synthesizing alpha- (2-tetrahydrofuryl) -acetophenone compound
CN110862311B (en) Synthesis method of 1-hydroxycyclopropanecarboxylic acid and carboxylate
CN101519380A (en) Method for preparing compound containing 1,2,3-triazole cinnamic acid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20210316